Litcius/Paper detail

Artificial sweeteners are related to non-alcoholic fatty liver disease: Microbiota dysbiosis as a novel potential mechanism

Hadi Emamat, Hamid Ghalandari, Hadith Tangestani, Afsoun Abdollahi, Azita Hekmatdoost

2020PubMed28 citationsDOIOpen Access PDF

Abstract

microorganisms play several roles in host nutrition, bone mineralization, immune system regulation, xenobiotics metabolism, proliferation of intestinal cells, and protection against pathogens. A disruption in composition of the normal microbiota is known as 'gut dysbiosis' which may adversely affect body metabolism. It has recently been suggested that dysbiosis may contribute to the occurrence of NAFLD. The aim of the present study was to investigate the effects of ASs on the risk of NAFLD. The focus of this review is on microbiota changes and dysbiosis. Increasing evidence shows that ASs have a potential role in microbiota alteration and dysbiosis. We speculate that increased consumption of ASs can further raise the prevalence of NAFLD. However, further human studies are needed to determine this relationship definitively.

Topics & Concepts

DysbiosisGut floraFatty liverMicrobiomeBiologyImmune systemDiseaseMedicinePhysiologyImmunologyBioinformaticsInternal medicineDiet, Metabolism, and DiseaseLiver Disease Diagnosis and TreatmentDiet and metabolism studies
Artificial sweeteners are related to non-alcoholic fatty liver disease: Microbiota dysbiosis as a novel potential mechanism | Litcius